HA/CD44 Regulates the T Helper 1 Cells Differentiation by Activating Annexin A1/Akt/mTOR Signaling to Drive the Pathogenesis of EAP

CD44 partcipates in multiple inflammatory reactions. Here, we aimed to investigate the role of CD44 and the ligand, hyaluronan (HA), on chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) pathogenesis. We found that CD44 was universally expressed in CD4+ lymphocytes in the peripheral blood of CP/CPPS patients. After silencing CD44 expression or delivering 4-methylumbelliferone (4-MU), the pain severity and prostatic inflammation were significantly relieved. In vitro assay found that HA/CD44 was able to regulate T helper 1 (Th1) cells differentiation, the deficiency of which diminished experimental autoimmune prostatitis (EAP) susceptibility. Bioinformatic analysis suggested that after HA or 4-MU treatment, mTOR signaling was significantly altered, and these results were confirmed by subsequent Western blotting assay. Besides, mass spectrometry and co-immunoprecipitation assays found that CD44 was able to interact with Annexin A1 (ANX A1), and this kind of interaction stabilized ANX A1 protein and maintained the activation of Akt/mTOR pathway. Meanwhile, HA-treatment-enhanced prostatic inflammation, Th1 cell differentiation, and Akt/mTOR pathway activation were reversed after silencing the expression of ANX A1 using shANX A1-lentivirus. The present study systematically investigates the functional role of HA/CD44 in CP/CPPS and identifies novel mechanisms for HA/CD44 promoting Th1 cell differentiation. Targeting the HA/CD44/ANX A1/Akt/mTOR signaling represents novel potential therapeutic strategies for patients with CP/CPPS.

[1]  C. Liang,et al.  4‐Methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy for chronic prostatitis , 2021, The Prostate.

[2]  C. Liang,et al.  Single‐cell multi‐omics analysis presents the landscape of peripheral blood T‐cell subsets in human chronic prostatitis/chronic pelvic pain syndrome , 2020, Journal of cellular and molecular medicine.

[3]  C. Liang,et al.  Single-Cell Multiomics Analysis Presents the Landscape of the Peripheral Blood T-Cell Subsets in Human Chronic Prostatitis/Chronic Pelvic Pain Syndrome , 2020 .

[4]  G. Tsokos,et al.  Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus , 2019, Front. Immunol..

[5]  J. Nickel,et al.  Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. , 2013, European urology focus.

[6]  Y. Numakura,et al.  Effect of tadalafil on chronic pelvic pain and prostatic inflammation in a rat model of experimental autoimmune prostatitis , 2018, The Prostate.

[7]  K. Nakayama,et al.  Akt1-mediated Gata3 phosphorylation controls the repression of IFNγ in memory-type Th2 cells , 2016, Nature Communications.

[8]  Xiansheng Zhang,et al.  AB220. Relationships between intravaginal ejaculatory latency time and National Institutes of Health-Chronic Prostatitis Symptom Index in the four types of premature ejaculation syndromes: a large observational study in China , 2016, Translational Andrology and Urology.

[9]  I. Prinz,et al.  IL-17 is not essential for inflammation and chronic pelvic pain development in an experimental model of chronic prostatitis/chronic pelvic pain syndrome , 2016, Pain.

[10]  L. Steinman,et al.  Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization , 2016, Proceedings of the National Academy of Sciences.

[11]  A. Schaeffer,et al.  Immune mediators of chronic pelvic pain syndrome , 2014, Nature Reviews Urology.

[12]  C. Liang,et al.  Relationships between intravaginal ejaculatory latency time and national institutes of health-chronic prostatitis symptom index in the four types of premature ejaculation syndromes: a large observational study in China. , 2014, The journal of sexual medicine.

[13]  F. D’Acquisto,et al.  The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis , 2012, Annals of the rheumatic diseases.

[14]  M. Nagarkatti,et al.  CD44 Reciprocally Regulates the Differentiation of Encephalitogenic Th1/Th17 and Th2/Regulatory T Cells through Epigenetic Modulation Involving DNA Methylation of Cytokine Gene Promoters, Thereby Controlling the Development of Experimental Autoimmune Encephalomyelitis , 2011, The Journal of Immunology.

[15]  Y. Li,et al.  The prevalence of prostatitis-like symptoms in China. , 2009, The Journal of urology.

[16]  M. Nagarkatti,et al.  Role of CD44 in the Differentiation of Th1 and Th2 Cells: CD44-Deficiency Enhances the Development of Th2 Effectors in Response to Sheep RBC and Chicken Ovalbumin1 , 2009, The Journal of Immunology.

[17]  M. Pontari,et al.  Mechanisms in prostatitis/chronic pelvic pain syndrome. , 2008, The Journal of urology.

[18]  E. Turley,et al.  CD44 Involvement in Autoimmune Inflammations , 2007, Annals of the New York Academy of Sciences.

[19]  Giuseppe Penna,et al.  Spontaneous and Prostatic Steroid Binding Protein Peptide-Induced Autoimmune Prostatitis in the Nonobese Diabetic Mouse1 , 2007, The Journal of Immunology.

[20]  F. D’Acquisto,et al.  Annexin-1 modulates T-cell activation and differentiation. , 2007, Blood.

[21]  C. Doglioni,et al.  Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol1 , 2006, The Journal of Immunology.

[22]  V. Rivero,et al.  Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens. , 2005, Human reproduction.

[23]  I. Otterness,et al.  Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice. , 2001, Arthritis and rheumatism.

[24]  M. Mohamadzadeh,et al.  Development of a Peptide Inhibitor of Hyaluronan-Mediated Leukocyte Trafficking , 2000, The Journal of experimental medicine.

[25]  R. Stern,et al.  Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  I. Weissman,et al.  Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Barry,et al.  How common is prostatitis? A national survey of physician visits. , 1998, The Journal of urology.

[28]  T. Glant,et al.  Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis , 1995, Nature Medicine.